Genmab A/S (CPH:GMAB)
1,702.00
-19.00 (-1.10%)
Jun 26, 2026, 4:59 PM CET
Genmab Employees
Genmab had 2,973 employees as of December 31, 2025. The number of employees increased by 339 or 12.87% compared to the previous year.
Employees
2,973
Change (1Y)
339
Growth (1Y)
12.87%
Revenue / Employee
8.19M DKK
Profits / Employee
1.72M DKK
Market Cap
104.49B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 67,900 |
| Coloplast | 17,083 |
| ALK-Abelló | 2,759 |
| Demant | 26,704 |
| H. Lundbeck | 5,000 |
| Zealand Pharma | 544 |
| Ambu A/S | 5,200 |
| Bavarian Nordic | 1,861 |
Genmab News
- 10 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 11 days ago - Major Shareholder Announcement - GlobeNewsWire
- 12 days ago - Genmab (GMAB) Reports Promising Results for Epcoritamab in DLBCL Studies - GuruFocus
- 12 days ago - Genmab announces new data from studies evaluating epcoritamab - TheFly
- 13 days ago - Genmab Presents Promising Epcoritamab Data In Elderly DLBCL Patients - Nasdaq
- 13 days ago - Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Business Wire
- 15 days ago - Grant of Restricted Stock Units and Warrants to Employees in Genmab - GlobeNewsWire
- 15 days ago - Genmab (GMAB) Reports Strong Data from EPCORE FL-1 Trial Analysis - GuruFocus